HI
TAK icon

HBK Investments’s Takeda Pharmaceutical TAK Stock Holding History

HBK Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,637,550
Closed -$45.4M – 744
2019
Q3 		$45.4M Hold
2,637,550
– – 0.58% 16
2019
Q2 		$46.7M Sell
2,637,550
-1,900
-0.1% -$34.6K 0.41% 20
2019
Q1 		$53.8M Buy
+2,639,450
New +$53.1M 0.54% 20

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

HBK Investments's TAK Position: Q4 2019 in Review

HBK Investments sold out of Takeda Pharmaceutical (TAK) in Q4 2019, closing a stake of 2,637,550 shares — an estimated $45.4M sold.

HBK Investments first reported a position in TAK in Q1 2019 and held it in 3 quarters. The position peaked at $53.8M in Q1 2019. 339 funds tracked by Wall St. Rank hold TAK as of Q4 2019.

  • HBK Investments reported no remaining Takeda Pharmaceutical position as of Q4 2019 after selling out during the quarter.
  • HBK Investments sold 2,637,550 Takeda Pharmaceutical shares in Q4 2019, an estimated $45.4M.
  • HBK Investments first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 3 quarters.
  • HBK Investments's Takeda Pharmaceutical position peaked at $53.8M in Q1 2019.
  • 339 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2019.

Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.